Privia Health appoints Dr. Opella Ernest to its Board of Directors and Compliance Committee, effective September 1, 2026.
Quiver AI Summary
Privia Health Group, Inc. announced the appointment of Dr. Opella Ernest to its Board of Directors, effective September 1, 2026. Dr. Ernest, who has over 20 years of healthcare executive experience, will also serve on the Compliance Committee. Privia's Chairman, David King, expressed excitement about her clinical expertise and experience in value-based care, which will support the company's growth in building provider networks across the U.S. Dr. Ernest has held leadership positions, including President at Health Care Service Corporation, and is a board-certified family physician. Privia Health is a major physician enablement company focused on transforming healthcare delivery and improving outcomes for patients and providers.
Potential Positives
- Appointment of Dr. Opella Ernest to the Board of Directors enhances the company's leadership with her extensive clinical expertise and experience in value-based care.
- Dr. Ernest's background as President of HCSC Markets and her previous roles in transforming customer and provider experiences highlight her capability to drive strategic growth for Privia Health.
- The addition of Dr. Ernest to the Compliance Committee signals a commitment to strong governance and regulatory compliance, potentially improving stakeholder trust.
Potential Negatives
- While the appointment of Dr. Ernest to the Board may be seen as a positive move, it raises questions about the need for new leadership at such a high level, potentially indicating dissatisfaction with the current board's performance.
- The inclusion of a Safe Harbor statement highlights the inherent risks and uncertainties associated with the company's future performance, which could lead to investor skepticism regarding its growth prospects.
- Dr. Ernest’s dual role and prior responsibilities at HCSC might spark concerns regarding potential conflicts of interest or divided attention given her commitments to multiple organizations.
FAQ
Who is Opella Ernest, M.D.?
Opella Ernest, M.D. is the newly appointed board member of Privia Health Group, Inc., effective September 1, 2026.
What experience does Dr. Ernest bring to Privia Health?
Dr. Ernest has over 20 years of healthcare executive experience, including roles at Health Care Service Corporation.
What position has Dr. Ernest been appointed to at Privia Health?
Dr. Ernest has been appointed to the Board of Directors and the Compliance Committee at Privia Health.
What is the mission of Privia Health?
Privia Health's mission is to transform healthcare delivery for better outcomes, lower costs, and improved community health.
How many states does Privia Health operate in?
Privia Health operates in 25 states and the District of Columbia, optimizing over 1,300 physician practices.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PRVA Insider Trading Activity
$PRVA insiders have traded $PRVA stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $PRVA stock by insiders over the last 6 months:
- MATTHEW SHAWN MORRIS has made 0 purchases and 8 sales selling 306,532 shares for an estimated $7,970,840.
- PARTH MEHROTRA (Chief Executive Officer) has made 0 purchases and 10 sales selling 286,123 shares for an estimated $6,425,441.
- DAVID MOUNTCASTLE (EVP & Chief Financial Officer) has made 0 purchases and 13 sales selling 113,608 shares for an estimated $2,871,533.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PRVA Revenue
$PRVA had revenues of $632.6M in Q2 2026. This is an increase of 21.39% from the same period in the prior year.
You can track PRVA financials on Quiver Quantitative's PRVA stock page.
You can access data on PRVA stock through the Quiver Quantitative API.
$PRVA Hedge Fund Activity
We have seen 157 institutional investors add shares of $PRVA stock to their portfolio, and 155 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 2,344,507 shares (+12.3%) to their portfolio in Q2 2026, for an estimated $60,324,165
- WELLINGTON MANAGEMENT GROUP LLP added 1,906,187 shares (+850.6%) to their portfolio in Q2 2026, for an estimated $49,046,191
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,374,828 shares (+inf%) to their portfolio in Q2 2026, for an estimated $35,374,324
- RIVERBRIDGE PARTNERS LLC removed 919,351 shares (-23.5%) from their portfolio in Q2 2026, for an estimated $23,654,901
- FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ added 863,660 shares (+455.5%) to their portfolio in Q2 2026, for an estimated $22,221,971
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 630,886 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $16,232,696
- NUVEEN, LLC added 517,009 shares (+54.5%) to their portfolio in Q2 2026, for an estimated $13,302,641
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$PRVA Price Targets
Multiple analysts have issued price targets for $PRVA recently. We have seen 5 analysts offer price targets for $PRVA in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $24.0 on 05/26/2026
- Richard Close from Canaccord Genuity set a target price of $34.0 on 05/08/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $26.0 on 04/08/2026
- Daniel Grosslight from Citigroup set a target price of $32.0 on 03/03/2026
- Jailendra Singh from Truist Securities set a target price of $33.0 on 03/02/2026
Full Release
ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026. She has also been named a member of the Compliance Committee of the Board.
“We are excited to welcome Dr. Ernest to our Board of Directors,” said David King, Chairman of the Board, Privia Health Group, Inc. “She brings valuable clinical expertise and value-based care experience to the Board and her deep healthcare expertise will be beneficial to Privia Health as we continue to grow our business and build scaled provider networks across the United States.”
Dr. Ernest has over 20 years of healthcare executive experience. Since 2023, she has served as President, HCSC Markets at Health Care Service Corporation, responsible for the strategic direction, clinical operations, performance, and growth for all market segments. She served as Executive Vice President, Chief Operating Officer at HCSC from 2021 to 2023, transforming HCSC’s customer and provider experience through advancements in technology and innovation. Prior to joining HCSC in 2012, Dr. Ernest held leadership roles at Healthspring and in various clinical practices.
A board-certified family physician, Dr. Ernest has a degree in medicine from The Ohio State University College of Medicine and a bachelor’s degree from the University of Michigan. Dr. Ernest is a member of the boards of directors of World Business Chicago and the Museum of Science and Industry. She is the former Chair of the American Heart Association’s Metro Chicago board of directors and received the 2021 Heart of Gold Award for her dedication addressing health issues.
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 6.1+ million patients, and reward 5,600+ physicians and advanced practitioners for delivering high-value care. Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit
priviahealth.com
and connect with us on
LinkedIn
.
Safe Harbor Statement
This release may contain forward-looking statements within the meaning of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company’s control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in filings with the Securities and Exchange Commission (“SEC”), including those under “Risk Factors” therein. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date made. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
Contact:
Robert Borchert
SVP, Investor & Corporate Communications
[email protected]
817.783.4841
